Subviral particle as vaccine and vaccine platform.

Curr Opin Virol · 2014 · PMC4072748 · PMID 24662314

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Since all these viral pathogens are prevalent in the developing countries, further study to develop their subviral particles into cost-effective vaccines and vaccine platform for broad application in the developing world is highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.